Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 580 Records) |
Query Trace: ABCG2[original query] |
---|
ABCC1, ABCG2 and FOXP3: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis. Biomedicines 2023 9 11 (9): . Cristina Membrive-Jiménez, Sayleth Vieira-Maroun, Noelia Márquez-Pete, Yasmin Cura, Cristina Pérez-Ramírez, Jesús Tercedor-Sánchez, Alberto Jiménez-Morales, María Del Carmen Ramírez-Torto |
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 9 167 115479. Elena Peruzzi, Lorenzo Gerratana, Marcella Montico, Bianca Posocco, Serena Corsetti, Michele Bartoletti, Sara Gagno, Marco Orleni, Elena De Mattia, Massimo Baraldo, Erika Cecchin, Fabio Puglisi, Giuseppe Toffoli, Rossana Ronca |
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1. Clinical pharmacokinetics 2023 9 . Mirjam de With, Leni van Doorn, Esmay Kloet, Anne van Veggel, Maja Matic, Micha J de Neijs, Esther Oomen-de Hoop, Esther van Meerten, Ron H N van Schaik, Ron H J Mathijssen, Sander Bi |
Genetic polymorphisms are associated with individual susceptibility to dexmedetomidine. Frontiers in genetics 2023 9 14 1187415. Yuanyuan Ding, Aiqing Liu, Yafeng Wang, Shuai Zhao, Shiqian Huang, Hongyu Zhu, Lulin Ma, Linlin Han, Shaofang Shu, Lidong Zheng, Xiangdong Ch |
ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban. Drug design, development and therapy 2023 8 17 2513-2522. Hamin Kim, Tae-Jin Song, Jeong Yee, Dong-Hyeok Kim, Junbeom Park, Hye Sun Gw |
Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation. Cancer chemotherapy and pharmacology 2023 8 . Shiyu He, Qianhang Shao, Jinxia Zhao, Jialu Bian, Yinyu Zhao, Xu Hao, Yuanyuan Li, Lei Hu, Boyu Liu, Huan He, Lin Huang, Qian Jia |
Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus. Pharmacogenomics 2023 8 . Noelia Pérez-Gómez, María Dolores Fernández-Ortega, Miren Elizari-Roncal, Estefanía Santos-Mazo, Laura de la Maza-Pereg, Sara Calvo, Raquel Alcaraz, Antonio Sanz-Solas, Raquel Vinuesa, Miriam Saiz-Rodrígu |
The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation. Human genomics 2023 7 17 (1): 59. Tingting Wu, Shuyi Wu, Li Li, Jing Xiang, Na Wang, Wenjun Chen, Jinhua Zha |
Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic-pharmacokinetic and exposure-response analysis. Cancer chemotherapy and pharmacology 2023 7 . Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, Yuji Okuda, Mariko Asano, Masahide Takeda, Katsutoshi Nakayama, Masatomo Miu |
Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants. Pharmacogenetics and genomics 2023 7 . K Ivar Lönnberg, Aleksi Tornio, Päivi Hirvensalo, Jenni Keskitalo, Anna-Liina Mustaniemi, Johanna I Kiiski, Anne M Filppula, Mikko Nie |
NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 6 165 115058. Gonzalo Villapalos-García, Pablo Zubiaur, Dolores Ochoa, Paula Soria-Chacartegui, Marcos Navares-Gómez, Miriam Matas, Gina Mejía-Abril, Ana Casajús-Rey, Diana Campodónico, Manuel Román, Samuel Martín-Vílchez, Carmen Candau-Ramos, Marina Aldama-Martín, Francisco Abad-Sant |
Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C?>?T (rs7668258) or UGT1A4*3 c.142 T?>?G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy. European journal of clinical pharmacology 2023 6 . Nada Božina, Ivana Šušak Sporiš, Iva Klarica Domjanovi?, Lana Ganoci, Livija Šimi?evi?, Mila Lovri?, Zrinka ?olak Romi?, Željka Petelin Gadže, Vladimir Trkul |
Comparative analysis of MTP -493G/T and ABCG2 34G/A polymorphisms and theirs expression in HIV-associated lipodystrophy patients. Frontiers in cardiovascular medicine 2023 6 10 1177054. HariOm Singh, Chandrashekhar Jori, Shyamveer, Supriya D Mahajan, Ravikumar Aalinkeel, Kathiravan Kaliyappan, Stanley A Schwartz, Meenakshi Bhattacharya, Ruhi Shaikh, Madhukar Salve, Jyoti Deshmukh, Nemat Ali, Mohammad Khalid Parv |
GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study. Journal of human genetics 2023 6 . Masatoshi Ueda, Kenji Fukui, Naoyuki Kamatani, Shigeo Kamitsuji, Akira Matsuo, Tomohiko Sasase, Jun Nishiu, Mutsuyoshi Matsushi |
Genetic Predictors of Antipsychotic Efflux Impairment via Blood-Brain Barrier: Role of Transport Proteins. Genes 2023 5 14 (5): . Regina F Nasyrova, Natalia A Shnayder, Sofia M Osipova, Aiperi K Khasanova, Ilya S Efremov, Mustafa Al-Zamil, Marina M Petrova, Ekaterina A Narodova, Natalia P Garganeeva, German A Shipul |
The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing. Pharmacogenomics 2023 5 . Khalifa Alrajeh, Ola AlAzzeh, Youssef Rom |
Case report: Hepatotoxicity and nephrotoxicity induced by methotrexate in a paediatric patient, what is the role of precision medicine in 2023? Frontiers in pharmacology 2023 5 14 1130548. Ali El Rida El Masri, Caroline Tobler, Breunis Willemijn, Andre O Von Bueren, Marc Ansari, Caroline Flora Sam |
Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer. EClinicalMedicine 2023 5 59 101955. G D Marijn Veerman, Rene J Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J van der Wekken, Idris Bahce, Lizza E L Hendriks, Sander Croes, Christi M J Steendam, Evert de Jonge, Stijn L W Koolen, Neeltje Steeghs, Ron H N van Schaik, Egbert F Smit, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H J Mathijss |
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 2023 3 13 (3): . Saiz-Rodríguez Miriam, Ochoa Dolores, Zubiaur Pablo, Navares-Gómez Marcos, Román Manuel, Camargo-Mamani Paola, Luquero-Bueno Sergio, Villapalos-García Gonzalo, Alcaraz Raquel, Mejía-Abril Gina, Santos-Mazo Estefanía, Abad-Santos Francis |
Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 2023 3 24 (6): . Cantara Silvia, Dalmiglio Cristina, Marzocchi Carlotta, Sagnella Alfonso, Brilli Lucia, Trimarchi Andrea, Maino Fabio, Valerio Laura, Castagna Maria Graz |
Single-nucleotide polymorphisms link gout with health-related lifestyle factors in Korean cohorts. PloS one 2023 12 18 (12): e0295038. Hye Kyung Jeon, Hae Young Y |
Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing. The pharmacogenomics journal 2023 11 . Jai N Patel, Myra Robinson, Sarah A Morris, Elizabeth Jandrisevits, Karine Eboli Lopes, Alicia Hamilton, Nury Steuerwald, Lawrence J Druhan, Belinda Avalos, Edward Copelan, Nilanjan Ghosh, Michael R Grunwa |
CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients. Frontiers in pharmacology 2023 11 14 1222435. Teerapat Majam, Chonlaphat Sukasem, Thanyanan Reungwetwattana, Phichai Chansriwong, Chalirmporn Atasilp, Narumol Trachu, Thanaporn Thamrongjirapat, Rattanaporn Sukprasong, Jennis Meanwattha |
Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. Fundamental & clinical pharmacology 2023 10 . Ivana Šušak Sporiš, Nada Božina, Iva Klarica Domjanovi?, Davor Sporiš, Silvio Baši?, Ivana Baši?, Mila Lovri?, Lana Ganoci, Vladimir Trkul |
Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children. Journal of acquired immune deficiency syndromes (1999) 2024 1 . Stephen A Spector, Sean S Brummel, Audrey Chang, Andrew Wiznia, Theodore D Ruel, Edward P Acosta, |
[Establishment of a genotyping method for the junior blood group and identification of a rare blood type with partial DVI.3 and Jr(a-)]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2024 1 41 (1): 52-58. Shuang Liang, Chunyan Mo, Xiaoyang Liu, Yanli Ji, Yanlian Liang, Fan Wu, Guangping Luo, Yuqing |
Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population. Current vascular pharmacology 2024 1 . Mais N Alqasrawi, Zeina N Al-Mahayri, Hiba Alblooshi, Habiba Alsafar, Bassam R A |
Vitamin D receptor induces oxidative stress to promote esophageal squamous cell carcinoma proliferation via the p53 signaling pathway. Heliyon 2024 1 10 (1): e23832. Qi-Xin Shang, Yu-Shang Yang, Han-Lu Zhang, Ya-Ping Cheng, Han Lu, Yong Yuan, Long-Qi Chen, Ai-Fang |
Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout. Disease markers 2024 1 2024 5930566. Ji?í Vávra, Kate?ina Pavelcová, Jana Mašínová, Lenka Hasíková, Eliška Bubeníková, Aneta Urbanová, Andrea Man?íková, Blanka Stib?rko |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: